PULMONARY TOXICITY STUDIES OF BLEOMYCIN AND TALISOMYCIN

被引：0

作者：

SCHLEIN, A

SCHURIG, JE

BACA, C

BRADNER, WT

CROOKE, ST

机构：

[1] BRISTOL MYERS CO LABS,RES & DEV,SYRACUSE,NY 13201

[2] BAYLOR COLL MED,DEPT PHARMACOL,HOUSTON,TX 77030

[3] BRISTOL MYERS CO LABS,DEPT PHARMACOL,SYRACUSE,NY 13201

来源：

CANCER TREATMENT REPORTS | 1981年 / 65卷 / 3-4期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：291 / 297

页数：7

共 13 条

[1]

ADAMSON IYR, 1974, AM J PATHOL, V77, P185

[2]

BRADNER WT, 1978, BU2231 3RD GENERATIO, P333

[3]

CRYSTAL RG, 1974, FED PROC, V33, P2248

[4]

DELENA M, 1972, CANCER CHEMOTH REP 1, V56, P343

[5]

IMINASHI H, 1978, J ANTIBIOT TOKYO, V31, P667

[6] TALLYSOMYCIN A NEW ANTI-TUMOR ANTIBIOTIC COMPLEX RELATED TO BLEOMYCIN .1. PRODUCTION, ISOLATION AND PROPERTIES [J].

KAWAGUCHI, H ;

TSUKIURA, H ;

TOMITA, K ;

KONISHI, M ;

SAITO, K ;

KOBARU, S ;

NUMATA, K ;

FUJISAWA, K ;

MIYAKI, T ;

HATORI, M ;

KOSHIYAMA, H .

JOURNAL OF ANTIBIOTICS, 1977, 30 (10) :779-788

[7]

Matsuda A., 1978, BLEOMYCIN CURRENT ST, P299

[8]

SCHLEIN A, 1979, CURRENT CHEMOTHERAPY, V2, P1707

[9]

SIKIC BI, 1979, P AM ASSOC CANC RES, V20, P182

[10]

SIKIC BI, 1978, CANCER RES, V38, P782

← 1 2 →